Category Archives: Biotechnology

How Marc Beer Became An Entrepreneur

He had no idea it would turn out this way but Marc Beer would eventually go on to become a business owner with a particularly successful career. So how was he able to do so well for himself in a career that has endured for over three decades? The 48-year-old businessman, philanthropist, and entrepreneur recently sat down to discuss how he managed to overcome adversity and not let any setbacks stand in his way. It all began when he was a freshman in college. This is when he dipped his toe into the world of business and realized that was what he wanted to do with his life. As such, he decided to major in it and he excelled in his coursework. This is why he finished in the top ten of his class and later received his bachelor of science degree in the spring of 87.

He later received his first job offer and decided to take it. He worked at three different companies over the course of the next twelve years and spent this time saving up enough money to become an entrepreneur someday. This dream was finally realized in the spring of 2000 when he became the owner of his own business known as Viacell. It’s not clear why but he would end up selling the company seven years later. Before he did, however, it thrived under his leadership and was even worth upwards of $300 million at one point. They also had a significant amount of employees but it later closed down after the passing of his wife. 

He turned his back on his career so he could subsequently stay home with the kids to comfort them and make sure they had everything they needed. Eventually, two years went by and that’s when he finally realized he was ready to get back to the philanthropy world. This is what led him to start a new company which would become known as Renovia. Created just a few years ago, this new business is specifically designed to create a wide variety of medical products to aid patients who are currently feeling ill or under the weather. The FDA has already endorsed one of their products which means that consumers can use it without fear of it being defective or useless. A grant has recently been awarded to them and it is worth a significant amount of money. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html

In a recent statement, he provided those who are looking to become like him with sound advice. During this time, he told them to always learn from any mistakes they have made in the past, ensure that their economic plan is stable before starting their own business and, most importantly, be willing to make sacrifices to ensure the success of the company. In addition to Renovia, he has also done some philanthropic work with one of the cancer foundations that strives to help people with the disease as well as their families. He serves as an excellent example for future generations.

Follow Marc Beer on Facebook

Marc Beer Reviews The Renovia’s Leva Pelvic Digital Therapeutic Study

From 1987 to the 1990s, Marc Beer pursued a career in marketing and sales with a strong focus in
the pharmaceutical and biotech industry. He worked for Abbott Laboratories and Genzyme and
gained much knowledge in the commercialization and development of biotechnology and
diagnostics. In the 2000s, Beer started a variety of companies including ViaCell and the most
recent business startup, Renovia which he established in 2017 with Dr. Iglesias and Yolanda Lorie.
Renovia is a med-technology company in Boston, Massachusetts specializing in the development
and testing of therapeutic and diagnostic devices. After the release of the company’s pilot study of
the Leva Pelvic Digital device, Marc is proud of its positive results.

The Renovia Pilot Study comprised 23 women in pre-menopausal with pelvic floor disorders which
lasted for six weeks. The objective of the study was to measure the usability and effectivity of the
Leva’s therapeutic technology in improving quality of life activities, PFM function, and urinary
incontinence. Each participant had to perform PFM exercises under the supervision of a research
assistant for five days weekly as an out-patient. Participants also had training sessions in the
privacy of their homes using the Leva pelvic digital therapeutic and diagnosis technology. Marc
Beer had the study published in Neurology & Urodynamics on August 7th, 2019 with positive
reviews and results.

Review Of The Renovia Pilot Study
 87 percent of the women showed a resolution of stress urinary incontinence symptoms.
 74 percent of the participants reported more high levels of improvement in UI symptoms.
 All the women reported improvement in general urinary incontinence symptoms.
 Participants with mixed UI reported resolution of urgency UI component.
 One percent of the women found the study was frustrating mildly because of its incontinence.
 99 percent improvement rate in the participants’ IIQ-7 scores.
 All participants except for one reported the Leva pelvic digital therapeutic and diagnostic
devices were easy to use.
 Symptoms reduced after the first week of the training sessions.
 Significant reduction in urinary incontinence symptoms and negative impact of UI during daily
activities performance. Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html

The FDA approved Renovia’s Leva Pelvic Digital Therapeutic in 2018 for use in the United States.
Marc Beer sees the results of the Renovia Pilot Study promising in furthering the expansion of the
product to help relieve the UI symptoms in women diagnosed with pelvic floor disorders. Since
starting Renovia, the Miami University graduate mission is to bring awareness of the effectiveness
of Leva’s products in reducing and eliminating the symptoms of pelvic floor disorders. Renovia is
also testing three other Leva developments which are solutions to strengthening the muscles of the
pelvic.

Connect with Marc Beer on Facebook

Marc Beer

Igor Cornelsen knows more about international markets and currencies than almost anyone else in the world. He spends much of his free time keeping tabs on the world’s markets and behaviors. He has a knack for spotting critical changes before others notice anything. That talent allows him to accurately predict events, which gives him an obvious competitive edge.

The best example of his predictive power was his thoughts about the Euro persisting when others predicted total failure. He predicted that the Euro could survive the European recession as long as it remained the only currency. As the recession ended, Euro’s value stalled and remained high enough to allow enough countries to fully recover, proving Igor Cornelsen correct.

As a Brazilian-born investor, Igor Cornelsen consistently boasts Brazil’s potential to investors. Though the country went through a recession in 2016, it bounced back much quicker due to political instability in the United States. As the US’s current President continues damaging the US’s reputation, more countries are looking to Brazil.

Brazil doesn’t offer huge profits like the US, but it does offer amble passive income opportunities. Much of Cornelsen’s audience works multiple jobs to make ends meet, and passive income is a way to make money without direct involvement.

Why do so many people trust Igor Cornelsen’s advice? Igor Cornelsen is a living example of his advice’s success; he takes his own advice all the time and proves himself right. It’s easy for people, even those without his level of education, to understand what he’s talking about because he’d done it himself.

Also, the most important factor in investing, according to Mr. Cornelsen is the source of information. Rather than sell people pages of data, he gives them what he used. Learn more: https://www.facebook.com/people/Marc-Beer/100009146215501

Marc Beer Conquers The Biotech Industry

Marc Beer is an entrepreneur which focuses on Biotechnology. He is known for his vast experience in leading startups related to the industry. With his 25 years of experience, there is no doubt that he had already mastered the formula if creating successful startups. His success and experience can be found in the wide array of successful companies under his name.

 

In 1987, Marc Beer received his bachelor’s degree in Business from Miami University. After studying, he went on to forge a career that enables him to show his leadership skills. Beer became the Vice President of Global Marketing at Genzyme, a company that focuses on developing products for people that suffer from rare diseases. With Genzyme, rare diseases are further researched, which aims to help more than 350 million patients globally.

 

The experience form Genzyme inspired Mark Beer to start his first-ever company, ViaCell. He founded the company in 2000. Seven years later, the company is already a successful biotechnology giant that employed 300 people and became a public company in 2005 on both NASDAQ and VIAC. ViaCell is a company that specializes in the collection and preservation of umbilical cord blood stems. Beer sold ViaCell to PerkinElmer for $300 million.

 

Marc Beer met a tragedy when her wife died of pulmonary embolism. For two years, Beer had focused on raising his three children full-time and pushed back his plans for more business ventures. His 14-year old daughter convinced him to go back on track and live with purpose, and that’s the reason why Beer once again tried his luck in building another company. In 2016, Beer launched his latest company, Renovia.

 

As of the moment, Marc Beer is the co-founder, the Chief Executive Officer, and the chairman of Renovia. The company develops products that help in diagnosing and treatment of pelvic floor disorders, a condition in which millions of women worldwide have. The idea for Renovia came to Beer when he received a phone call from Dr. Ray Iglesias, a gynecologist who has been facilitating surgeries for women who have pelvic floor disorders for 35 years.

 

Together with Yolanda Lorie and Dr. Iglesias, Marc Beer co-founded Renovia, which is headquartered in Boston. Its goal is to provide products that help in the treatment and diagnosis of conditions such as pelvic organ prolapse, urinary incontinence, and fecal incontinence. It is reported that almost 25% of women in the US are affected by these conditions. Just last year, the company released its first-ever product, Leva, which is already approved by the FDA.

 

Renovia also managed to get a Series B round of funding for $32 million in addition to the $10 million in venture funding. The funds will be used in the development of other products that aim to combat pelvic floor disorders.  Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html

Marc Beer

Marc Beer has more than 25 years of development experience in the biotechnology, diagnostics, and pharmaceutical industries. In his skilled years of entrepreneurial success, he has created and developed companies that have reached top achievements. Marc graduated from Miami University in 1987 having received a Bachelor of Science degree in Business. Learn more: https://www.facebook.com/people/Marc-Beer/100009146215501

 

His first solo success was at the pharmaceutical company of Genzyme, where he became Vice President of Global Marketing. His first venture was at ViaCell in 2000 where he took this biotechnology company all the way a listing on NASDAQ. ViaCell specialized in the preservation of umbilical cord blood stem cells in order to treat a number of health issues. 

 

Marc Beer’s many successes have always had a goal of helping anyone who was suffering in hard to diagnose health issues. Not only has he founded and built-up healthcare companies through research and development, but he has also had an impact as he served on many health-related boards. These achievements have included the following:

 

o Board member of the Commonwealth of Massachusetts

o Board member of the Biotechnology Innovation Organization 

o Member of the Erytech Pharma

o Board member of the Notre Dame Research and Commercialization Advisory Committee

o Notre Dame Graduate Studies Research and Advisory Council

o Member of the Miami University Business Advisory Council

o Board member of the Joe Andruzzi Cancer Foundation

o Member of the Minerva Neurosciences, Inc. 

 

In an interview, Marc was asked how he was inspired to start Renovia. He said he was approached by two colleagues studying a muscular dysfunction in the body’s pelvic floor. They asked Marc to help with the technical background and the executive leadership to help secure funding. 

 

Marc was further asked to lead the venture and the rest is history. With Mr. Beer’s astute skill in marketing, he was asked which marketing strategy he has used that worked so well that it created a new business.

 

Mr. Beer remarked that it had to be working with the FDA to have them approve a specific prescription-based product for Renovia. The product could only be approved by a physician’s referral. Marc said that he and his great marketing team was successful, but that this same strategy has worked in their introducing products that gained marketing appeal on TV, marketing channels, radio, and online platforms.

 

When asked what makes him successful, Marc stated that he works hard and he works with great people who are talented, driven and experts in their field. Not to diminish his own drive, Marc Beer has always championed causes to improve mankind’s health issues. 

 

In addition, he uses his leadership and natural problem-solving skills to make the lives of others, a better one. He also inspires the medical experts around him and is committed to improving the lives of the medical community and their patients. Marc believes in attempting to bridge the gap between health/medical problems and a workable solution.